SOSivakumar Oruganti

Sivakumar Oruganti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sivakumar Oruganti has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Siske Struik

    Paediatric Critical Care Unit, Noah's Ark Children's Hospital for Wales, Cardiff, UK

    2 shared publications
  • Angela Strang

    School of Medicine, Cardiff University, Cardiff, UK

    1 shared publication
  • Anna Barrow

    Paediatric Critical Care Unit, Noah's Ark Children's Hospital for Wales, Cardiff, UK

    1 shared publication
  • Assim Javaid

    Cardiff University Cardiff UK

    1 shared publication
  • Awen Evans

    Children's and Young Adults Research Unit, University Hospital of Wales, Cardiff, UK

    1 shared publication
  • Barbara Paquete

    Paediatric Critical Care Unit, Noah's Ark Children's Hospital for Wales, Cardiff, UK

    1 shared publication

Latest Publications

  • Wales Infants’ and childreN’s Genome Service (WINGS): providing rapid genetic diagnoses for unwell children

    by Emily Sloper, Jana Jezkova, Joanne Thomas, Kestra Dawson, Joseph Halstead, Jennifer Gardner, Katherine Burke, Sivakumar Oruganti, Jennifer Calvert, Jennifer Evans, et al.

    Introduction This study reviews the first 3 years of delivery of the first National Health Service (NHS)-commissioned trio rapid whole genome sequencing (rWGS) service for acutely unwell infants and children in Wales. Methods Demographic and phenotypic data were prospectively collected as patients and their families were enrolled in the Wales Infants’ and childreN’s Genome Service (WINGS). These data were reviewed alongside trio rWGS results. Results From April 2020 to March 2023, 82 families underwent WINGS, with a diagnostic yield of 34.1%. The highest diagnostic yields were noted in skeletal dysplasias, neurological or metabolic phenotypes. Mean time to reporting was 9 days. Conclusion This study demonstrates that trio rWGS is having a positive impact on the care of acutely unwell infants and children in an NHS setting. In particular, the study shows that rWGS can be applied in an NHS setting, achieving a diagnostic yield comparable with the previously published diagnostic yields achieved in research settings, while also helping to improve patient care and management.


  • Open Access

    Immune and metabolic markers for identifying and investigating severe Coronavirus disease and Sepsis in children and young people (pSeP/COVID ChYP study): protocol for a prospective cohort study

    by Sivakumar Oruganti, Patrícia R S Rodrigues, Daniel White, William John Watkins, Selyf Shapey, Anna Barrow, Rim al Samsam, Sara Ali, Malcolm Gajraj, Richard Skone, et al.

    Introduction Early recognition and appropriate management of paediatric sepsis are known to improve outcomes. A previous system’s biology investigation of the systemic immune response in neonates to sepsis identified immune and metabolic markers that showed high accuracy for detecting bacterial infection. Further gene expression markers have also been reported previously in the paediatric age group for discriminating sepsis from control cases. More recently, specific gene signatures were identified to discriminate between COVID-19 and its associated inflammatory sequelae. Through the current prospective cohort study, we aim to evaluate immune and metabolic blood markers which discriminate between sepses (including COVID-19) from other acute illnesses in critically unwell children and young persons, up to 18 years of age. Methods and analysis We describe a prospective cohort study for comparing the immune and metabolic whole-blood markers in patients with sepsis, COVID-19 and other illnesses. Clinical phenotyping and blood culture test results will provide a reference standard to evaluate the performance of blood markers from the research sample analysis. Serial sampling of whole blood (50 μL each) will be collected from children admitted to intensive care and with an acute illness to follow time dependent changes in biomarkers. An integrated lipidomics and RNASeq transcriptomics analyses will be conducted to evaluate immune-metabolic networks that discriminate sepsis and COVID-19 from other acute illnesses. This study received approval for deferred consent. Ethics and dissemination The study has received research ethics committee approval from the Yorkshire and Humber Leeds West Research Ethics Committee 2 (reference 20/YH/0214; IRAS reference 250612). Submission of study results for publication will involve making available all anonymised primary and processed data on public repository sites. Trial registration number NCT04904523.

  • Remember the heart: neonatal myocarditis

    by Khuen Foong Ng, Jack Gibb, Siske Struik, Peter J Davis, Peter Muir, Chris Gillett, Sivakumar Oruganti, Marion Roderick


  • Open Access

    Identification of sepsis in paediatric emergency departments: A scoping review

    by Sivakumar Oruganti, Jordan Evans, Thomas Cromarty, Assim Javaid, Damian Roland

    Aim: Sepsis is an acute illness associated with significant morbidity and mortality. Early detection and time‐sensitive management of sepsis has been shown to improve outcomes. We report the results of a scoping review to explore methods evaluated for the identification of sepsis in children presenting to emergency departments.Methods: A systematic literature search was carried out on two databases, Medline and Web of Science, to identify relevant studies published from 1990 to 2022. Data were extracted for age groups including study design, reference standard used for comparison, sepsis identification method evaluated and study quality.Results: A total of 89 studies were identified from the literature search. There was significant heterogeneity in the age groups including study design and reference standards used for evaluating the performance of the sepsis identification methods. There has been a substantial increase in the number of published studies in the last 2 years.Conclusion: Our scoping review identifies marked heterogeneity in approaches to identifying sepsis but demonstrates a recent focus of research on patient outcomes. Using appropriate core outcome sets, developing reference standards, monitoring sepsis prevalence via registries and continuously monitoring process measures will provide robust evidence to identify the best performing identification tools and the impact they have on patient‐orientated outcomes.